Safety, Pharmacokinetics, and Pharmacodynamics of SHR-2004, a Novel Humanized Monoclonal Antibody Targeting Factor XI, in Patients with Atrial Fibrillation: An Open-Label Phase 1b Study
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40262-026-01720-7
文献链接: https://link.springer.com/article/10.1007/s40262-026-01720-7
其他信息:
出版社: Springer Science and Business Media LLC
作者: Jun Jiang; Yaping Wang; Yumin Zhang; Ping Zhang; Jiahui Wu; Yang Lin; Guohai Su; Qing Wen; Jiawen Ye; Yanli Dong; Yuqi Wang; Jianan Wang
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40262-026-01720-7.pdf

